Cancer Site* | Person-years | Observed | Expected | SIR (95% CI) | p |
---|---|---|---|---|---|
All sites | 1300 | 52 | 18.7 | 2.77 (2.07–3.64) | < 0.001 |
All sites excluding SCC | 1399 | 34 | 18.7 | 1.81 (1.26–2.54) | 0.001 |
SCC | 1375 | 26 | 2.02 | 12.85 (8.40–18.83) | < 0.001 |
Prostate | 1468 | 7 | 4.21 | 1.66 (0.67–3.43) | 0.129 |
Bladder | 1485 | 5 | 1.16 | 4.30 (1.40–10.04) | 0.003 |
Colorectal | 1482 | 5 | 2.80 | 1.78 (0.58–4.17) | 0.130 |
Lung | 1502 | 3 | 1.70 | 1.77 (0.36–5.16) | 0.186 |
Pancreas | 1502 | 3 | 0.43 | 7.00 (1.44–20.45) | 0.002 |
Breast | 1491 | 2 | 2.51 | 0.80 (0.10–2.88) | 0.919 |
↵* Ordered by decreasing numbers of observed cancer cases. SIR: standardized incidence ratios; ANCA: anti-neutrophil cytoplasmic antibody; SCC: squamous cell carcinoma.